Certified by Founder Lodge
Apollo Therapeutics
United Kingdom - Cambridge, England
START UP
1 Disclosed Funding Rounds $226,500,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Apollo Therapeutics is a biopharmaceutical company rapidly advancing a robust pipeline of potentially transformative therapeutic programs based on breakthrough discoveries. Through deep relat
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 11 ,2023 | Series C | $226,500,000 | |
| January, 03 ,2024 | Series C | $33,500,000.00 |
Rock Springs Capital
Patient Square Capital
M&G plc
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
InCharge Energy | $46,000,000 | (Jun 5, 2026)
Forage | $40,000,000 | (Jun 5, 2026)
ZutaCore | $100,000,000 | (Jun 5, 2026)
Quobly | $133,545,475 | (Jun 5, 2026)
Oak Hill Bio | $32,500,000 | (Jun 5, 2026)
